ABT · Categories · Coverage
ABT - Analyst coverage initiated
Abbott Laboratories (ABT) analyst coverage initiated - real-time wire coverage filtered to Coverage only.
Recent Coverage for ABT
- The Benchmark Company initiated coverage on Abbott Labs with a new price targetThe Benchmark Company initiated coverage of Abbott Labs with a rating of Buy and set a new price target of $145.00
- Leerink Partners initiated coverage on Abbott Labs with a new price targetLeerink Partners initiated coverage of Abbott Labs with a rating of Market Perform and set a new price target of $143.00
- Oppenheimer initiated coverage on Abbott Labs with a new price targetOppenheimer initiated coverage of Abbott Labs with a rating of Outperform and set a new price target of $130.00
- Piper Sandler initiated coverage on Abbott Labs with a new price targetPiper Sandler initiated coverage of Abbott Labs with a rating of Overweight and set a new price target of $131.00
- Goldman initiated coverage on Abbott Labs with a new price targetGoldman initiated coverage of Abbott Labs with a rating of Buy and set a new price target of $121.00
- UBS initiated coverage on Abbott Labs with a new price targetUBS initiated coverage of Abbott Labs with a rating of Buy and set a new price target of $117.00
- Mizuho initiated coverage on Abbott Labs with a new price targetMizuho initiated coverage of Abbott Labs with a rating of Neutral and set a new price target of $105.00
- Barclays initiated coverage on Abbott Labs with a new price targetBarclays initiated coverage of Abbott Labs with a rating of Overweight and set a new price target of $118.00
- Jefferies initiated coverage on Abbott Labs with a new price targetJefferies initiated coverage of Abbott Labs with a rating of Hold and set a new price target of $110.00
- Wolfe Research initiated coverage on Abbott Labs with a new price targetWolfe Research initiated coverage of Abbott Labs with a rating of Underperform and set a new price target of $95.00
- RBC Capital initiated coverage on Abbott Laboratories with a new price targetRBC Capital initiated coverage of Abbott Laboratories with a rating of Outperform and set a new price target of $146.00
- Redburn Partners initiated coverage on Abbott LaboratoriesRedburn Partners initiated coverage of Abbott Laboratories with a rating of Neutral
- Barclays initiated coverage on Abbott Labs with a new price targetBarclays initiated coverage of Abbott Labs with a rating of Overweight and set a new price target of $150.00
- Atlantic Equities initiated coverage on Abbott Labs with a new price targetAtlantic Equities initiated coverage of Abbott Labs with a rating of Neutral and set a new price target of $122.00